.svg)
We only facilitate KAP with licensed mental health professionals. These licensed psychotherapists are required to maintain an active professional license and adhere to the standards of their licensing boards. To join our network, all Journey Clinical members are required to upload their credentials to our platform and adhere to our professional guidelines. We do not facilitate KAP with coaches or unlicensed guides.
Safe Medical Care, Trusted Psychotherapy
Together, we have delivered 200,000+ hours of Ketamine-Assisted Psychotherapy (KAP).
Am I A Candidate?
Your Dedicated Care Team
Journey Clinical patients are supported by a dedicated care team of clinicians who work together to ensure their safety and well‑being. The combination of medical care with trusted psychotherapy allows for more frequent breakthroughs and longer lasting results. Learn more our commitment to patient safety.
Our Expert Medical Team
Our team has supervised the safe and personalized treatment of thousands of patients across the United States.
Dr. Kyle Lapidus, MD, PhD
Medical Director
Dr. Kyle Lapidus is Journey Clinical’s Medical Director, overseeing psychiatric care across multiple states. He earned his BA magna cum laude from Harvard University and his MD and PhD from Albert Einstein College of Medicine, completing his psychiatry residency at Mount Sinai’s Icahn School of Medicine, where he conducted cutting-edge research on ketamine.
Board-certified by the American Board of Psychiatry and Neurology, Dr. Lapidus continues to advance novel treatments for mood and anxiety disorders through clinical research and innovative service delivery.
Dr. Boris Heifets, MD, PhD
Scientific Advisor
Dr. Boris Heifets is Journey Clinical’s Scientific Advisor, a board-certified anesthesiologist at Stanford and a leading researcher in psychedelic neuroscience. He earned his BS in Neuroscience from Yale, his MD and PhD from Albert Einstein College of Medicine, and completed his residency, fellowship, and postdoctoral research at Stanford, where he is now an Assistant Professor in Anesthesiology with a courtesy appointment in Psychiatry.
At Stanford, Dr. Heifets leads a research lab studying ketamine, MDMA, and psilocybin, investigating how these therapies drive lasting brain changes to improve mental health outcomes.
.webp)
Dr. Brigitte Gordon DNP, PMHNP-BC
Lead Prescriber
Dr. Brigitte Gordon is a board-certified psychiatric nurse practitioner specializing in adult and geriatric psychiatry with a focus on integrative care. She earned her BS in Nursing, MA in Nursing, and DNP in Nursing from Columbia University, following studies at Temple University and the University of Pennsylvania.
An assistant professor at Columbia University School of Nursing, Dr. Gordon has contributed to research with MAPS. She is the founder of Hudson Mental Wellness, a private practice in Dobbs Ferry, NY. Her experience spans emergency, consultation-liaison, and geriatric psychiatry.
.webp)
Dr. Kwasi Adusei, DNP, PMHNP-BC
Clinical Advisor
Dr. Kwasi Adusei is a psychiatric mental health nurse practitioner, specializing in psychedelic-assisted therapy and harm reduction. He co-founded the Psychedelic Society of Western New York and led the Sanctuary Project, a grassroots initiative focused on psychedelic harm reduction.
A MAPS-trained MDMA-Assisted Psychotherapy provider, Dr. Adusei was part of the first cohort of therapists of color in the program. His expertise in community mental health and clinician training informs his clinical practice.
Our licensed medical professionals have completed comprehensive training in Ketamine-Assisted Psychotherapy.
The Journey Clinical Difference:
Why Therapy Matters
Unlike at-home ketamine treatments or IV infusions, which only target neurochemical relief, we use ketamine as a supplement to therapy for deeper emotional exploration.
All Journey Clinical patients undergo continuous psychotherapy with a licensed mental health professional.
Therapy You Can Trust
Partner with one of over 2500 therapists in our network to receive the highest standard of care with KAP.
.png)
Choose Your Licensed Psychotherapist
Mandatory KAP Training for Therapists
Therapists on our platform must complete our comprehensive KAP education module (designed by Fluence) in order to start practicing KAP, or have proof of training from vetted organizations (e.g. Fluence, Polaris, CIIS, MAPS, etc), as well as participate in peer consultation groups and experiential learning.
.webp)
KAP Clinical Protocols with Preparation, Dosing, and Integration
Our care model integrates ketamine with structured psychotherapy before, during, and after each dosing session. Under the supervision of a licensed mental health professional, patients undergo preparation, dosing and integration sessions. This protocol enables patients to process emotions, insights, and experiences within the therapeutic setting, leading to lasting behavioral and emotional changes and improved clinical outcomes.
Our Commitment to Safety Every Step of the KAP Experience
1. Comprehensive Psychiatric Care
Journey Clinical’s medical team takes on a comprehensive, holistic view of each patient and their psychiatric care, ensuring personalized treatment aligned to individual needs and goals. Read the patient code of conduct. Learn more about Medication Management.
2. Thorough Medical Screening with Medical Clearances
Before treatment, all patients undergo a 1-hour medical intake consultation covering their medical and psychiatric history, the risk/benefit framework of ketamine, and potential contraindications, with medical clearances from other providers if needed. All Journey Clinical patients sign an informed consent form that comprehensively informs them that ketamine is being prescribed off-label as well as the potential risks and side effects of the medication.
3. Strict Dosing Protocol & Follow-up
Journey Clinical only prescribes ketamine in the context of Ketamine-Assisted Psychotherapy (KAP), in which a patient is in a therapeutic alliance with a licensed psychotherapist in our network. To start, patients receive two doses to determine the appropriate dosage and to prevent any potential misuse. To receive any additional prescriptions, patients must come back for follow-up consultations with our medical team.
4. Experience KAP in a Controlled Environment
All patients experience Ketamine-Assisted Psychotherapy with a therapist present in person or remotely (in addition to a designated chaperone). Patients are continuously monitored throughout the dosing process by a trained licensed psychotherapist offering real-time support and helping to navigate challenging emotions to ensure safety and therapeutic efficacy.
5. Vitals Monitoring
During dosing sessions, patients self-administer vitals (blood pressure, heart rate) before taking their medicine, which is logged in Journey Clinical’s HIPAA-compliant portal by their therapist and monitored by the medical team for safety and compliance.
6. Ongoing Support from Your Dedicated Care Team
Your care team works collaboratively to ensure continuous support, fostering an open dialogue so that you always feel informed, empowered, and supported. Journey Clinical’s medical team conducts regular follow-ups to monitor treatment progress and provide ketamine lozenge refills as appropriate.
Follow-up frequency is tailored to each patient’s individualized treatment plan, with a minimum of one per quarter. More about our commitment to patient safety
.png)
The combination of medical care with trusted psychotherapy enables deep emotional processing and lasting mental health outcomes.
Experience KAP today with the support of a dedicated care team committed to safe and compassionate care.